Chargement en cours...
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study
Background: We investigate the role of family history of cancer (FHC) and diagnosis of metachronous and/or synchronous multiple neoplasms (MN), during anti-PD-1/PD-L1 immunotherapy. Design: This was a multicenter retrospective study of advanced cancer patients treated with anti-PD-1/PD-L1 immunother...
Enregistré dans:
Publié dans: | Oncoimmunology |
---|---|
Auteurs principaux: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artigo |
Langue: | Inglês |
Publié: |
Taylor & Francis
2020
|
Sujets: | |
Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6959456/ https://ncbi.nlm.nih.gov/pubmed/32002308 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2019.1710389 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|